New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export NVAX’s income statement to Excel — free account
Novavax, Inc.
NVAXNovavax, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.1 billion, up 64.7% from fiscal 2024.
- Revenue
- −3.05%
- EPS
- n/m
- Free cash flow
- n/m
- Total debt
- +19.3%
Quarter to September 2026, against a year earlier
7.74
0.01
+0.13%
Follow NVAX
Alert me
What it owns vs. what it owes Q3 FY2026, Sep 30, 2026
It holds $328.8M more in cash and short-term investments than it owes in debt. Debt has risen from $246.3M to $293.6M since Q4 FY25. Liabilities are $216.9M more than assets: shareholders’ equity is negative. What is a balance sheet?
Owns
$180.0MLong-term assets
$85.6MOther short-term assets
$622.4MCash & short-term investments
Funded by
$811.2MOther liabilities
$293.6MDebt
Debt is 33.1% of the total; liabilities are $216.9M more than assets.
Net cash fell from 42% of assets to 37% since Q4 FY25.
Net debt ÷ assets (right axis)
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Total assets | $1.2B | $1.0B | $956M | $888M |
| Net debt (debt less cash) | −$500M | −$497M | −$426M | −$329M |
| Net debt ÷ assets (right axis) | −42.5% | −47.7% | −44.6% | −37.0% |
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
+8 more quarters Free account |
745.96 | 790.33 | 719.34 | 622.36 |
Receivables |
106.45 | 23.31 | 18.74 | 49.16 | |
Inventory |
11.55 | 11.46 | 10.01 | 18.50 | |
Other current assets |
87.51 | — | — | — | |
Total current assets |
978.28 | 850.82 | 771.10 | 707.96 | |
Property, Plant, Equpment (Net) |
44.80 | 42.15 | 38.13 | 36.28 | |
Goodwill and Intangible Assets (Total) |
113.46 | 112.89 | 112.54 | 112.08 | |
Long-term assets (Other) |
17.08 | 15.95 | 13.96 | 13.40 | |
Total non-current assets |
198.24 | 192.35 | 184.48 | 180.05 | |
Total Assets |
1,176.51 | 1,043.16 | 955.58 | 888.01 | |
Accounts Payable |
24.58 | 16.10 | 22.94 | 24.94 | |
Accrued Expenses |
107.17 | 103.03 | 81.42 | 77.40 | |
Current Part of Capital Lease |
2.51 | 2.11 | 4.11 | 1.65 | |
Current Revenue (Deferred) |
140.05 | 88.77 | 86.58 | 102.20 | |
Other current liabilities |
185.65 | 132.45 | 135.53 | 123.65 | |
Total current liabilities |
459.95 | 342.46 | 330.57 | 329.85 | |
Long Term Debt (Total) |
246.30 | 292.95 | 293.21 | 293.61 | |
Non-current Revenue (Deferred) |
358.94 | 359.27 | 356.76 | 330.01 | |
Non-current Liabilities (Other) |
239.07 | 193.24 | 165.74 | 151.39 | |
Total non-current liabilities |
844.32 | 845.46 | 815.71 | 775.02 | |
Total liabilities |
1,304.27 | 1,187.92 | 1,146.28 | 1,104.86 | |
Additional Paid In Capital |
4,539.76 | 4,548.59 | 4,558.46 | 4,567.17 | |
Common Stock (Net) |
1.65 | 1.68 | 1.68 | 1.68 | |
Retained Earnings |
(4,568.15) | (4,577.64) | (4,631.03) | (4,662.40) | |
Treasury Stock |
103.02 | 112.32 | 112.37 | 112.48 | |
Common Equity (Total) |
(127.75) | (144.76) | (190.71) | (216.85) | |
Shareholders Equity (Total) |
(127.75) | (144.76) | (190.71) | (216.85) | |
Shareholders Equity and Liabilities (Total) |
1,176.51 | 1,043.16 | 955.58 | 888.01 | |
Shares (Common) |
162.58 | 164.42 | 164.82 | 164.99 | |
Shareholders Equity (Tangible) |
(241.22) | (257.65) | (303.25) | (328.93) | |
Net Debt |
(499.66) | (497.39) | (426.13) | (328.75) | |
Total Debt |
246.30 | 292.95 | 293.21 | 293.61 |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026